Brain death–associated ischemia and reperfusion injury
Authors:
- Johann PratschkeJPJohann Pratschke
- Hans-Dieter VolkHVHans-Dieter Volk
- 1 June 2004
- journal article
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 9 (2) , 153-158
Abstract
The donor-associated risk factor of brain death is closely associated with ischemia and reperfusion injury. This article outlines the interference between brain death–induced graft alterations and conditions after reperfusion injury during the pretransplantation and early posttransplantation periods. Unrelated living donor kidney transplants have a better long-term outcome than cadaver donor grafts despite a poorer human lymphocyte antigen match. Prolonged cold ischemia in cadaver donors has been identified as one important risk factor influencing graft outcome. In addition to its nonspecific injury effects, it enhances graft immunogenicity and host alloresponsiveness. Occurring early in the transplant process, it initiates a cascade of molecular and cellular events, including the release of proinflammatory mediators and attraction of various cell types infiltrating the tissues. As a consequence, acute and chronic changes develop that influence the structure and function of the organ, which may contribute to reduced graft survival. Originally considered an event surrounding organ procurement, preservation, and revascularization, it has recently been associated with donor conditions such as brain death. Experimental data have shown that brain death is an independent risk factor that induces similar pathophysiologic features as ischemia and reperfusion. Indeed, brain death–induced proinflammatory changes in donor organs show a pattern comparable to that seen after prolonged cold organ ischemia. Thus, brain death and ischemia and reperfusion injury can no be longer categorized as nonimmune, antigen-independent events. Brain death and ischemia and reperfusion have a synergistic negative impact on long-term allograft outcome by enhancing graft immunogenicity and host alloresponsiveness. In the authors’ opinion, graft-preserving strategies should start shortly after brain death diagnosis to improve organ quality before the transplant procedure.Keywords
This publication has 38 references indexed in Scilit:
- Cadaveric versus living-donor livers: differences in inflammatory markers after transplantationTransplantation, 2003
- The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysisTransplantation, 2003
- High prevalence of decreased cortisol reserve in brain-dead potential organ donorsCritical Care Medicine, 2003
- Hormonal resuscitation yields more transplanted hearts, with improved early function1Transplantation, 2003
- Prognostic significance of free radicals: mediated injury occurring in the kidney donorTransplantation, 2003
- Ischemia/Reperfusion Injury in Human Kidney TransplantationThe American Journal of Pathology, 1998
- CHANGES IN ORGAN PERFUSION AFTER BRAIN DEATH IN THE RAT AND ITS RELATION TO CIRCULATING CATECHOLAMINES1Transplantation, 1996
- Analysis of Cadaver Donor Criteria on the Kidney Transplant Survival Rate in 5,129 TransplantationsJournal of Urology, 1995
- BOTH ALLOANTIGEN-DEPENDENT AND -INDEPENDENT FACTORS INFLUENCE CHRONIC ALLOGRAFT REJECTIONTransplantation, 1995
- CYTOKINES, ADHESION MOLECULES, AND THE PATHOGENESIS OF CHRONIC REJECTION OF RAT RENAL ALLOGRAFTSTransplantation, 1993